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Accelerated intoxication of
GABAergic synapses by botulinum
neurotoxin A disinhibits stem
cell-derived neuron networks prior to
network silencing
Phillip H. Beske, Stephen M. Scheeler, Michael Adler and Patrick M. McNutt *
Cellular and Molecular Biology Branch, Research Division, United States Army Medical Research Institute of Chemical
Defense, Aberdeen Proving Ground, MD, USA
Botulinum neurotoxins (BoNTs) are extremely potent toxins that specifically cleave
SNARE proteins in peripheral synapses, preventing neurotransmitter release. Neuronal
responses to BoNT intoxication are traditionally studied by quantifying SNARE protein
cleavage in vitro or monitoring physiological paralysis in vivo. Consequently, the
dynamic effects of intoxication on synaptic behaviors are not well-understood. We
have reported that mouse embryonic stem cell-derived neurons (ESNs) are highly
sensitive to BoNT based on molecular readouts of intoxication. Here we study the
time-dependent changes in synapse- and network-level behaviors following addition
of BoNT/A to spontaneously active networks of glutamatergic and GABAergic ESNs.
Whole-cell patch-clamp recordings indicated that BoNT/A rapidly blocked synaptic
neurotransmission, confirming that ESNs replicate the functional pathophysiology
responsible for clinical botulism. Quantitation of spontaneous neurotransmission in
pharmacologically isolated synapses revealed accelerated silencing of GABAergic
synapses compared to glutamatergic synapses, which was consistent with the selective
accumulation of cleaved SNAP-25 at GAD1+ pre-synaptic terminals at early timepoints.
Different latencies of intoxication resulted in complex network responses to BoNT/A
addition, involving rapid disinhibition of stochastic firing followed by network silencing.
Synaptic activity was found to be highly sensitive to SNAP-25 cleavage, reflecting
the functional consequences of the localized cleavage of the small subpopulation of
SNAP-25 that is engaged in neurotransmitter release in the nerve terminal. Collectively
these findings illustrate that use of synaptic function assays in networked neurons
cultures offers a novel and highly sensitive approach for mechanistic studies of
toxin:neuron interactions and synaptic responses to BoNT.
Keywords: botulinum neurotoxin, stem cell-derived neurons, SNAP-25, synaptic transmission, glutamatergic
synapse, GABAergic synapse, botulism
Beske et al. Complex CNS responses to BoNT/A
Introduction
Botulinum neurotoxins (BoNTs) are highly lethal bacterial tox-
ins produced by Clostridium botulinum, C. butyricum, and
C. barati (Simpson, 2004). Of the seven BoNT serotypes
(A–G) that are currently described, BoNT/A, /B, /E, and /F
have been directly associated with human disease (Simpson,
2004). The toxin is expressed as a single 150 kDa peptide,
which is proteolytically cleaved to produce a dichain com-
posed of a 100 kDa heavy chain (HC) and a 50 kDa light
chain (LC) linked by a disulfide bond (Singh, 2006). HC medi-
ates binding to pre-synaptic receptors on peripheral motorneu-
rons and autonomic neurons, facilitating toxin uptake via
synaptic endocytosis. LC then translocates to the neuronal
cytosol and specifically cleaves the soluble N-ethylmaleimide-
sensitive factor attachment protein receptors (SNAREs) SNAP-
25, VAMP1/2 or syntaxin-1a/b, which are functionally essential
for synaptic exocytosis. Cleavage of any of these proteins pre-
vents assembly of the conserved synaptic exocytosis complex,
thereby blocking neurotransmitter release and causing the neu-
romuscular and autonomic symptoms associated with clinical
botulism.
BoNT has been designated as a Tier 1 Select Agent because
of the high lethality, lack of therapeutic options and ease of
production and distribution. The combination of efficient neu-
ronal targeting and pre-synaptic activity renders BoNTs the
most potent toxins known, with estimated human lethal doses
as low as 0.1–1 ng/kg (Simpson, 2004). Clinical presentation
develops 2–36 h after exposure, depending on dose and route
of exposure, and is characterized by a generalized weakness
which progresses to a flaccid paralysis (Dembek and Alves,
2011). Botulism becomes life-threatening once the respiratory
muscles are affected, requiring mechanical ventilation and sup-
portive care to keep severely exposed patients alive. Depending
on the subtype, paralysis may persist for months. Despite the
severe physiological consequences of systemic intoxication, the
local delivery of small quantities of BoNT has been clinically
exploited for a wide array of indications. The exquisite selectiv-
ity and long duration of action have made clinical preparations
of BoNT highly effective for a multitude of neuromuscular and
autonomic disorders, as well as to treat chronic pain, promote
wound healing, and improve facial aesthetics (Naumann et al.,
2008).
Although passive immunization can be used to abstract neu-
rotoxin from circulation, antitoxin is ineffective once toxin has
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bound to or internalized into neurons (Simpson, 2004). Despite
identification of the intracellular target and proteolytic mecha-
nisms of BoNT/A in 1993, attempts to develop treatments that
reverse paralysis and restore normal synaptic transmission have
been unsuccessful (Blasi et al., 1993; Schiavo et al., 1993; Larsen,
2009). A major contributing factor to this failure is the lack of
a scalable, sensitive and relevant cell-based model of botulism
that replicates in vivo host:toxin interactions and is suitable for
therapeutic screening and mechanistic studies. While cultured
cell lines such as neuroblastomas or adrenal chromaffin cells can
be chemically induced to exhibit some neurotypic characteristics,
these cell lines have not been found to produce functioning pre-
and post-synaptic compartments (McNutt et al., 2011). Since the
pre-synaptic compartment is the physiological target of BoNT, it
is therefore unlikely that the full range of toxin:neuron interac-
tions are replicated in the absence of functioning synapses. Stud-
ies involving these cell models have reported poor sensitivities
to BoNTs and results have been inconsistent with in vivo studies
and primary neuron cultures (Eubanks et al., 2007; Larsen, 2009;
Hubbard et al., 2012).
Stem cell-derived neurons have recently been proposed as
a next-generation platform for neurotoxin research that unifies
the flexibility of cultured cell lines with the relevance of pri-
mary neurons (McNutt et al., 2011; Whitemarsh et al., 2012).
Mouse embryonic stem cell-derived neurons (ESNs) replicate
many unique in vivo characteristics of BoNT intoxication, includ-
ing serotype-specific persistences, activity-enhanced onset rates
and differential serotype potencies (McNutt et al., 2011; Hub-
bard et al., 2012). By 18 days after plating (DAP 18), ESNs
exhibit spontaneously active glutamatergic synapses and action
potential (AP) firing and intoxication with BoNT/A results in
SNAP-25 cleavage and blockade of K+-evoked glutamate release
(McNutt et al., 2011; Gut et al., 2013). Observations of sponta-
neous synaptic activity in ESNs led us to hypothesize that intox-
ication with BoNT/A would eliminate synaptic transmission,
thereby rendering synaptic function assays as a novel method
to functionally evaluate synapse- and network-level responses
to intoxication. Here we test this hypothesis by using whole-
cell patch-clamp recordings to evaluate longitudinal changes in
synaptic transmission following addition of BoNT/A to DAP 24+
ESNs, and find that synaptic function assays are significantly
more sensitive indicators of intoxication than aremolecular read-
outs of SNAP-25 cleavage. The resolution of this approach was
further increased by determination of time-to-50% inhibition
(T50i) values for isolated glutamatergic and γ-aminobutyric acid
(GABA)ergic synapses. The consequences of differential synapse-
specific T50i values to network-level behaviors were then stud-
ied using long-term current-clamp recordings. This is the first
high-resolution characterization of the effects of BoNT intox-
ication on synaptic activity and emergent responses in neural
networks. The establishment of a functionally relevant model
of synaptic paralysis at physiologically relevant concentrations
of BoNT is expected to accelerate mechanistic and therapeu-
tic studies of botulism as well as of a larger array of neu-
rotropic toxins that modulate synaptic activity and network
behaviors.
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Materials and Methods
Reagents and Cell Culture
Unless otherwise specified, reagents for electrophysiology were
obtained from Sigma-Aldrich (St. Louis, MO). Cell culture sup-
plies for embryonic stem cell maintenance, ESN differentiation
and ESN culture were obtained from Invitrogen (Carlsbad, CA).
R1 murine embryonic stem cells (ATCC, Manassas, VA) were
maintained, differentiated into ESNs and plated as previously
described (McNutt et al., 2011; Hubbard et al., 2012; Gut et al.,
2013). Experiments were conducted on ESNs between DAP 24
and 34. Data were collected from ESNs produced among 14
independent differentiations over 9 months, with no apparent
change in functional responses to intoxication. With the excep-
tion of superfusion studies, BoNT/A1 (BoNT/A; specific activ-
ity = 2.5 × 108U/mg; Metabiologics, Madison, WI) was diluted
to 2000 pM in appropriate buffers and added 1:100 to DAP 24+
ESNs for indicated durations. For binnedmeasurements of longi-
tudinal changes in mPSC, mEPSC, and mIPSC frequencies, each
dish was incubated in ESN medium plus toxin or vehicle control
until the start of the appropriate bin.
Electrophysiology
DAP 24+ neuron cultures were visualized on an Olympus IX51
microscope (Shinjuku, Tokyo, Japan) equipped with a 40× lens
with differential interference contrast optics. 5–10 M patch
pipettes were pulled from borosilicate glass (Sutter Instruments,
Novato, CA), backfilled with intracellular recording buffer and
dipped in Sigmacote R© (Sigma) prior to use. Electrophysiology
data were acquired at 20–22◦C with an EPC10 (Heka, Lam-
brecht/Pfalz, Germany) and Heka Patchmaster 2.53 software.
Current and voltagemeasurements were filtered online at 2.9 kHz
and digitized at 10 kHz. Data analysis and graphing were per-
formed in Heka Fitmaster 2.53, Igor Pro v6 (Wavemetrics, Port-
land, OR) and Prism v6.1 (Graphpad Software, La Jolla, CA).
ESNs were bathed in extracellular recording buffer (ERB) con-
taining (in mM): 140 NaCl, 3.5 KCl, 1.25 NaH2PO4, 2 CaCl2,
1 MgCl2, 10 Glucose, 10 HEPES (pH 7.3; 315 ± 10mOsm/Kg).
Potassium-based intracellular recording buffer (K-IRB) was used
to record miniature post-synaptic currents (mPSCs), miniature
excitatory post-synaptic currents (mEPSCs) and cell firing activ-
ity, containing (mM): 140 K-gluconate, 5 NaCl, 2 Mg-ATP, 0.5
Li-GTP, 0.1 CaCl2, 1 MgCl2, 1 EGTA, and 10 HEPES (pH 7.3;
315 ± 10mOsm/Kg). Cesium-based IRB (Cs-IRB) was used to
record mIPSCs, containing (in mM): 140 CsCl, 5 NaCl, 2 Mg-
ATP, 0.5 Li-GTP, 0.1 CaCl2, 1MgCl2, 1 EGTA, and 10HEPES (pH
7.3; 315± 10mOsm/Kg). All traces are compensated for junction
potentials of 15.6mV (K-IRB) or 4.6mV (Cs-IRB).
Resting membrane potential (RMP) was determined using the
zero-current-clamp method immediately after establishment of
whole-cell configuration. AP firing was evoked by current injec-
tion (1 s;−20 to 120 pA in 10 pA steps). Input resistance was esti-
mated by calculating the slope of the I-V relationship determined
from hyperpolarizing currents steps (1 s; −60 to 0 pA in 10 pA
steps). Time constants were determined by averaging the single
exponential decay rate (AxoGraph X, Berkeley, CA) of the −40
and −30 pA current steps (1 s). Rheobase was determined by the
amount of current necessary to elicit the first AP using a linear
ramp of depolarizing current injection (10 s; 0–200 pA). Single
AP properties (threshold, AP amplitude, afterhyperpolarization
amplitude) were measured on the first AP elicited in rheobase
recordings using the FitMaster linear measurement tool.
To record mPSCs, ERB was supplemented with tetrodotoxin
(TTX; 5µM) to eliminate APs. To record mEPSCs, ERB was
supplemented with TTX (5µM), bicuculline (10µM), and
CGP55845 (1µM) to eliminate APs, GABARA and GABARB
currents, respectively (Curtis et al., 1970; Deisz, 1999). To record
mIPSCs, TTX (5µM), 6-cyano-7-nitroquinoxaline-2,3-dione
(CNQX; 10µM), and (2R)-amino-5-phosphonopentanoate
(APV; 50µM) was added to ERB to block APs and eliminate
AMPAR and NMDAR currents (Davies and Watkins, 1982;
Long et al., 1990). Miniature currents were recorded over a
3min period in voltage-clamp mode at holding potentials of
−85.6mV (K-IRB) or −74.6mV (Cs-IRB). Holding currents
were between −25 and 0 pA. Spontaneous synaptic events were
detected and quantified in MiniAnalysis using default AMPAR
or GABARA detection parameters. The number of miniature
currents during each recording was quantified and converted
to Hz. Unless otherwise indicated, frequencies were normalized
to control data collected from age- and lot-matched neurons.
Kinetic parameters of miniature events were determined in
MiniAnalysis from 42 neurons for mEPSCs (averaged from
over 2400 events per neuron) and from 23 neurons for mIPSCs
(averaged from over 400 events per neuron). Peak-scaled traces
were averaged from over 100 mEPSC or mIPSC events.
For agonist-induced ionotropic glutamate receptor (iGluR)
and GABA receptor (GABAR) currents, at least four neurons
per treatment were superfused with agonists or inhibitors diluted
into ERB using a three-barrel Fast Step system (Warner Instru-
ments, Hamden, CT) and recorded in voltage-clamp mode.
AMPA (100µM) currents were measured in the presence of TTX
(5µM), APV (50µM), and bicuculline (10µM). NMDA (50µM)
currents were recorded with TTX (5µM), CNQX (10µM), and
bicuculline (10µM) in ERB containing 0 or 1mM Mg2+, as
described. Muscimol (100µM)currents were recorded in the
presence of TTX (5µM), APV (50µM), and CNQX (10µM).
Baclofen (10µM) currents were recorded with TTX (5µM),
CNQX (10µM), APV (50µM), and bicuculline (10µM). iGluR
and GABARB currents were recorded at a holding potential
of −85.6mV (K-IRB). GABARA currents were recorded at a
holding potential of−74.6mV (Cs-IRB).
For continuous current-clamp recordings, additional drugs
were not added to the ERB unless indicated. To measure sponta-
neous action potentials (AP) and excitatory post-synaptic poten-
tials (EPSP), 3–4min current-clamp recordings were conducted
at RMP. Spontaneous APs and EPSPs were detected using Mini-
Analysis v6 (Synaptosoft Inc., Fort Lee, NJ) with default detec-
tion settings and thresholds of 25mV for AP detection and 5mV
for EPSP detection. For long-duration current-clamp recordings,
APs were recorded from patched neurons in 6-cm dishes ini-
tially containing 2mL ERB. After the first 10min, 6mL of ERB
containing vehicle, toxoid, heat-denatured BoNT/A or active
BoNT/A was superfused at 1.5–2mL/min via gravity-fed plas-
tic tubing to a final concentration of 20 pM (BoNT/A and
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heat-denatured BoNT/A) or 200 pM (BoNT/A toxoid). For
burst characterization, APs were detected using the parameters
described above and then bursts were identified as 3 or more
APs with interspike intervals of less than 500ms. All data were
normalized to the 5min bin immediately preceding superfusion.
For all electrophysiology experiments, recordings were
accepted if the following criteria were met: RMP were between
−68 and −80mV; series resistances were less than 50M; and
resistances did not vary by more than 20% of starting value
throughout the recording.
Immunoassays
Protein lysates were generated from ESN cultures by scrap-
ing in ice-cold RIPA buffer, quantified by BCA (Pierce), sepa-
rated by SDS-PAGE and transferred to PVDF. Blots were stained
and imaged as previously described (Hubbard et al., 2012).
Primary antibodies used for Western blotting included SNAP-
25 (Covance, Princeton, NJ) and syntaxin-1 (Synaptic Systems,
Gottingen, Germany). For immunocytochemistry, ESNs on 18-
mm coverslips were fixed in 4% paraformaldehyde, permeabi-
lized with 1% saponin in TBS (TBS-S), treated with primary and
secondary antibodies diluted in TBS-S and imaged by confo-
cal microscopy as previously described (Mesngon and McNutt,
2011; Hubbard et al., 2012; Gut et al., 2013). Images were col-
lected on a Zeiss LSM-700 confocal microscope with a 40× objec-
tive. Primary antibodies against Tau (Synaptic Systems), MAP2
(Synaptic Systems), wild-type SNAP-25 (Covance), the cleaved
form of SNAP-25 (cSNAP-25; Research and Diagnostic Antibod-
ies, Las Vegas, NV), synapsin 1A/B (SYN1; Synaptic Systems),
vesicular glutamate transporter 2 (VGLUT2; Synaptic Systems),
and glutamate decarboxylase 1 (GAD1; Synaptic Systems) were
used for immunocytochemistry studies at manufacturer recom-
mended dilutions. For quantification of synapse subtypes, 8 cov-
erslips of DAP 24+ ESNs were triple stained for expression of
SYN1, VGLUT2 and GAD1 and fluorescent co-localization of
these three markers was evaluated on 250–500 synapses per
coverslip (≥2000 synapses in total). Quantitation of cSNAP-25
co-localization with VGLUT2 and GAD1 was performed in four
coverslips per timepoint, with at least 500VGLUT2 and 500
GAD1 synapses counted per coverslip and scored as cSNAP-25+
or cSNAP-25−. All immunocytochemistry quantitation studies
were conducted using three investigators blinded to the experi-
mental setup.
Statistical Analysis
Spontaneous activity and mEPSC/mIPSC frequencies were cal-
culated by determining the mean frequency (in Hz) of events
measured during continuous recordings among ≥8 neurons in
each condition. Rates measured in BoNT/A-treated neurons were
normalized to mean rates observed in age- and lot-matched
vehicle-treated neurons and presented as percentages of con-
trol rates. Normalization of inter-burst intervals and the num-
ber of APs/burst was conducted in a similar fashion, with the
5min of recording immediately preceding superfusion used as
baseline for normalization. In most cases, statistical significance
among means was determined using One-Way ANOVA testing
and P-values were calculated against controls with the Dunnett’s
post-hoc test. For long-duration current-clamp recordings, statis-
tical significance among normalized grouped means was deter-
mined using Two-Way ANOVA and P-values were calculated
with Bonferroni’s post-hoc test. In binary comparisons Student’s
t-test was used to determine significance between means. For
comparison of the distribution of glutamatergic vs. GABAer-
gic synapses, Shapiro-Wilk normality test was first performed
to confirm that data were normally distributed, followed by a
one-sample t-test comparing each population against a theoret-
ical mean of 50%. Unless otherwise stated, quantitative data are
presented as mean± the standard error of the mean, with the fol-
lowing levels of statistical significance: ∗ indicates a P < 0.05; ∗∗
indicates a P < 0.01; ∗∗∗ indicates a P < 0.001.
Results
ESN Cultures Produce Excitatory and Inhibitory
Synapses with Emergent Network Responses
DAP 24 ESNs exhibit polarized compartments and protein local-
ization consistent with synapse formation, including the pres-
ence of synaptic puncta at axodendritic interfaces (Figure 1A),
and express transcripts specific for glutamatergic and GABAer-
gic lineages (Hubbard et al., 2012). However, ESNs have not
been functionally characterized for expression of post-synaptic
receptors, onset of synaptic activity or emergence of network
behaviors. To evaluate the functional expression of glutamate
andGABA receptors, agonist-induced currents were evaluated by
whole-cell patch-clamp recordings in voltage-clamp mode. Bath
addition of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic
acid (AMPA) resulted in large inward currents, while the
addition of N-methyl-D-aspartate (NMDA) resulted in large
currents only when Mg2+ was absent from the extracellular
solution (Figure 1B). Perfusion with the ionotropic GABAA
receptor (GABARA)-agonist muscimol resulted in a large
desensitizing Cl− current, while the metabotropic GABAB
receptor (GABARB)- agonist baclofen produced a sustained
hyperpolarizing current (Figure 1B).
Miniature excitatory post-synaptic currents (mEPSCs) and
miniature inhibitory post-synaptic currents (mIPSCs) were
observed in DAP 24+ ESNs with mean frequencies of 10.2
± 1.4 and 1.3 ± 0.4Hz, respectively (Figure 1C). Miniature
events exhibited kinetic values consistent with glutamatergic and
GABAergic post-synaptic currents and were eliminated by addi-
tion of CNQX or bicuculline, respectively (Figure 1C). Charac-
terization of synapse subtypes was simultaneously conducted by
immunocytochemistry (ICC) co-localization of three markers:
the universal pre-synaptic marker synapsin I (SYN1), the glu-
tamatergic pre-synaptic marker VGLUT2 and the GABAergic
pre-synaptic marker GAD1. Co-localization studies confirmed
that 86.1% of SYN1 puncta could be unambiguously associated
with VGLUT2 or GAD1. Of these, 76.3± 4.4% were co-localized
with VGLUT2 while 23.7 ± 4.5% were co-localized with GAD1
(Figure 1D, S1). Frequent spontaneous excitatory post-synaptic
potentials (sEPSPs), APs and short bursts typically comprised
of 2–10 APs were evident in current-clamp mode, suggestive
of synaptically driven network behavior. Network behavior was
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FIGURE 1 | DAP 24+ ESNs produce functional glutamatergic and
GABAergic synapses with emergent network behavior. (A)
Representative ICC demonstrating expression of the pre-synaptic marker
SYN1 (white) at regions of axodendritic interface at DAP 24 (axonal
marker Tau, blue; somatodendritic marker MAP2, magenta). (B)
Representative voltage-clamp recordings showing receptor-mediated
currents following superfusion with AMPA (100µM), NMDA (50µM) with
or without Mg2+ in the extracellular buffer, muscimol (100µM) or baclofen
(10µM; n ≥ 4 each). (C) Detection of mESPCs in the presence of TTX
(5µM), bicuculline (10µM), and CGP55845 (1µM) and mIPSCs in the
presence of TTX (5µM), CNQX (10µM), and APV (50µM) on compressed
(left) and expanded (middle) time-scales. CNQX (10µM) or bicuculline
(10µM) eliminated mEPSCs or mIPSCs, respectively. Peak-scaled overlay
and table (right) summarize respective kinetic parameters (n = 11 each).
(D) Distribution of excitatory and inhibitory synaptic markers that
co-localized with SYN1 puncta (mean ± SD; n = 8). *** indicates
P < 0.001 vs. theoretical mean of 50% (dashed line). (E) Representative
current-clamp recordings of APs and EPSPs under baseline conditions
and following bicuculline (10µM) addition (left). Expanded time-scale
insets (right) are from region marked by • in original recordings. (F)
Representative current-clamp recordings following addition of TTX (5µM),
CNQX (10µM) or GABA (100µM; n ≥ 4 each).
further evaluated by superfusion of the GABARA antagonist
bicuculline, which converted stochastic AP firing to prolonged
epileptiform discharges (Figure 1E). Addition of TTX eliminated
spontaneous APs, while addition of CNQX or GABA eliminated
all APs and EPSPs (Figure 1F). The lack of spontaneous APs and
sEPSPs in the presence of CNQX suggests that APs result exclu-
sively from excitatory synaptic activity. Collectively, these data
demonstrate the functional development of glutamatergic and
GABAergic synapses and the emergence of emergent network
behaviors with characteristics of an excitatory/inhibitory (E/I)
balance.
BoNT/A Intoxication Eliminates Network Activity
Cleavage of the essential SNARE protein SNAP-25 by BoNT/A
prevents neurotransmitter release from the pre-synaptic com-
partment in peripheral neurons. In theory, BoNT/A-intoxication
of a neuronal network would therefore reduce or eliminate
synaptically driven network responses. To evaluate the effects
of BoNT/A on network behaviors, we quantified spontaneous
rates of EPSPs and APs at 20 h after the addition of 20 pM
BoNT/A. This combination of time and dose has been found to
cause the cleavage of ∼95% of total cellular SNAP-25 in ESNs
(McNutt et al., 2011). In current-clamp recordings, intoxication
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with BoNT/A eliminated over 99.1% of EPSPs and 99.8% of
APs compared to vehicle-treated controls (Figure 2A). To con-
firm that the reduction of APs was caused by the loss of synap-
tic drive rather than decreased intrinsic excitability, passive,
and active neuronal properties were compared between vehicle-
and BoNT/A-treated neurons (Figures 2B,C, S2). BoNT/A did
not elicit changes in RMP or capacitance and had no effect
on the ability of intoxicated neurons to fire APs in response
to current injection. However, intoxicated neurons exhibited
increased excitability, as demonstrated by increased membrane
resistance and reduced rheobase. Since these differences increase
the likelihood that neurons will fire APs in response to post-
synaptic events, they cannot be responsible for elimination of
spontaneous EPSPs and APs in BoNT/A-treated ESNs. There-
fore, these data suggest that BoNT/A-mediated loss of sponta-
neous activity is specifically attributable to impaired synaptic
neurotransmission.
Temporal Characterization of the Molecular and
Functional Responses to BoNT/A Intoxication in
Networked Neuron Cultures
The above data demonstrate that intoxication caused near-
complete silencing of network activity by 20 h after addi-
tion of BoNT/A. To narrow the temporal window during
which dynamic changes in synapse- and network-level behav-
iors could be characterized via higher-resolution methods, the
longitudinal production of cleaved SNAP-25 (cSNAP-25) was
used as a molecular readout of intoxication from 0 to 6 h
after bath addition of 20 pM BoNT/A (Figure 3A). In gel
mobility-shift assays, conversion of 2.7 ± 1.6% of total SNAP-
25 to the BoNT/A-cleaved product was first detectable by
2 h, followed by a progressive increase to 71.5 ± 8.2% at
6 h. To determine whether cSNAP-25 was specifically associ-
ated with nerve terminals, co-localization of cSNAP-25 with
SYN1 was evaluated by ICC from 0 to 4 h after BoNT/A
addition (Figure 3B). cSNAP-25 progressively accumulated at
SYN1+ puncta from 1 to 4 h, suggesting that LC was active
in pre-synaptic compartments within an hour after BoNT/A
addition.
Changes in the frequency of neurotransmission are typi-
cally attributable to altered pre-synaptic release probability. To
test the hypothesis that impaired pre-synaptic release of neu-
rotransmitter was responsible for the near-complete loss of
spontaneous APs and EPSPs following BoNT/A addition, we
developed the measured inhibition of synaptic transmission
(MIST) assay. MIST is based on comparing the frequencies
of miniature post-synaptic currents (mPSCs) between intoxi-
cated neurons and vehicle-treated controls, providing a quanti-
tative measurement of the functional effects of intoxication on
synaptic release probabilities. Based on the rapid appearance
of cSNAP-25 in nerve terminals, rates of synaptic transmission
were measured from 30 to 360min after bath addition of
BoNT/A (Figure 3C). Surprisingly, BoNT/A addition caused a
biphasic response in mPSCs, with an initial increase in fre-
quency between 30 and 49min (157.1 ± 38.3%) compared
to controls, followed by a steady decline to near-complete
FIGURE 2 | Intoxication of DAP 24+ ESNs with BoNT/A eliminates
synaptically driven EPSPs and AP firing. (A) Representative
current-clamp recordings of ESNs (left) 20 h after application of vehicle
(top) or 20 pM BoNT/A (bottom). BoNT/A dramatically reduces the
frequency of spontaneous APs and sub-threshold EPSPs compared to
vehicle-treated controls (n ≥ 18 each). *** indicates P < 0.001. (B) Both
vehicle-treated and BoNT/A-treated ESNs fire repeated APs in
response to depolarizing current injection (−20 to 120 pA, 10 pA
steps; n = 18 each). (C) Summary of passive and active membrane
properties of vehicle- and BoNT/A-treated ESNs (n = 18 each).
P-values are indicated for each pairwise comparison, with significant
differences in bold.
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FIGURE 3 | Time-dependent changes in cSNAP-25 production and
mPSC frequency following BoNT/A addition. (A) Representative western
blot (left) showing conversion of intact SNAP-25 (•) to cSNAP-25 (◦) as a
function-of-time after addition of 20 pM BoNT/A. The percentages of total
SNAP-25 that is converted to cSNAP-25 at each time point is presented at
right (n = 4 per timepoint). (B) Representative ICC of cSNAP-25 from 0 to
240min using an antibody specific for the cleaved product (left; n = 3 for each
timepoint). Higher magnification images (right) show co-localization of
cSNAP-25 (white) with the pre-synaptic label SYN1 (red). (C) Representative
voltage-clamp recordings performed in the presence of TTX (5µM) at
indicated time points following treatment with 20 pM BoNT/A (left). Summary
of normalized mean mPSC frequencies (right; n = 24 controls; n ≥ 8 at each
timepoint after BoNT/A addition). * indicates a P < 0.05; *** indicates a
P < 0.001; ns signifies not significant. Comparisons for significance are made
against 0min mean.
silencing of synaptic activity to 1.6 ± 0.5% of control activ-
ity by 360min. Since the only known function of LC/A is
to target and cleave SNAP-25, functionally preventing neu-
rotransmitter release, the finding that BoNT/A intoxication
caused a transient increase in mPSCs at 30–49min was unex-
pected.
Biphasic Responses to Intoxication Reflect the
Preferential Intoxication of GABAergic Synapses
at Early Timepoints
In the above studies, monosynaptic currents were measured at
the post-synaptic soma in a complex background containing both
excitatory and inhibitory synaptic events. In these types of net-
works, production of excitatory events can be obscured by the
effects of concurrent GABAergic signaling at pre-synaptic and
post-synaptic compartments, resulting in a lower apparent rate
of synaptic activity (Wang et al., 2003; Chalifoux and Carter,
2011). This led us to hypothesize that the transient increase in
mPSCs at 30–49min after BoNT/A addition could be caused by
the temporally selective intoxication of GABAergic synapses.
To test this hypothesis, we first determined whether GABAer-
gic signaling influenced detection of spontaneous synaptic
activity by directly comparing mPSC rates to pharmacologically
isolated mEPSC rates. The addition of GABARA and GABARB
antagonists increased detection of excitatory events by 160% (6.4
± 0.6Hz vs. 10.2± 1.4Hz; Figure 4A), confirming that GABAer-
gic activity can depress the detection of excitatory synaptic
events. Intriguingly, mEPSC rates were identical to mPSC rates
measured at 30–49min after BoNT/A addition (10.2± 1.4Hz vs.
10.1± 2.4Hz; p = 0.95), suggesting that the transient increase in
mPSCs at 30min might reflect selective intoxication of GABAer-
gic synapses. To directly determine whether GABAergic synapses
were silencedmore quickly than glutamatergic synapses, wemea-
sured longitudinal changes in mIPSC vs. mEPSC rates from 30
to 210min after addition of BoNT/A (Figure 4B). While aver-
age mIPSC frequencies were reduced by 74.7 ± 10.1% as soon as
30min after BoNT/A addition, reduction in mEPSC frequencies
was not observed until 70min after intoxication, when rates were
decremented by 51.1± 9.3%.
To more precisely characterize the time course of GABAergic
intoxication, mIPSCs were quantified in 10-min bins from 10 to
30min after addition of 20 pM BoNT/A. Since BoNT/A internal-
ization is mediated by activity-dependent synaptic endocytosis
(Simpson, 2004), it was likely that addition of BoNT/A in the
presence of TTX, which eliminates action potential-dependent
synaptic activity, would significantly alter the kinetics of toxin
uptake. Therefore, the 0–10min bin was not directly evaluated
using MIST. mIPSC frequency were reduced by 70.2 ± 5.9%
as soon as 10–19min after toxin addition (Figure 4C). Acceler-
ated GABAergic intoxication was corroborated by co-localization
ICC demonstrating the increased association of cSNAP-25 with
GAD1 puncta vs. VGLUT2 puncta (Figure 4D). Based on these
findings, the significantly shorter latency of intoxication of
GABAergic synapses (T50i < 10min) compared to glutamatergic
synapses (T50i ≈ 70min) offers a plausible mechanistic expla-
nation for the transient increase in mPSC rates observed at
30–49min after BoNT/A addition.
Preferential BoNT/A Intoxication of GABAergic
Synapses Rapidly Disinhibits Neuronal Networks
Continuous current-clamp recordings were used to indirectly
measure the effects of accelerated GABAergic impairment on
network activity following superfusion with 20 pM BoNT/A.
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FIGURE 4 | Functional and molecular evidence of accelerated
impairment of GABAergic synapses following addition of 20 pM
BoNT/A. (A) Representative voltage-clamp recordings (left) and mean event
frequencies (right) demonstrating that antagonism of GABAergic signaling
with bicuculline (10µM) and CGP55845 (1µM) increases the detection of
excitatory events (n = 10 each). (B) Representative voltage-clamp recordings
(left) and normalized mean frequencies (right) of mEPSC and mIPSC
frequencies from 30 to 110min after BoNT/A addition (n ≥ 9 per timepoint).
(C) Representative voltage-clamp recordings (left) and normalized mean
mIPSC frequencies (right) from 10 to 29min after BoNT/A addition (n ≥ 10
per timepoint). (D) Representative ICC images (top) and percentages of
GAD1+ and VGLUT2+ puncta (bottom) that are co-localized with cSNAP-25
from 0 to 120min after BoNT/A addition (n = 4 per timepoint). * indicates a
P < 0.05; ** indicates a P < 0.01; *** indicates a P < 0.001.
To increase the power and sensitivity of this approach, net-
work activity was normalized to baseline values measured 5min
prior to BoNT/A perfusion and compared to time-matched
data from control superfusions. Readouts of network activity
included normalized changes in inter-burst intervals, burst dura-
tions and APs per burst. To test for potential confounds, three
different control treatments were evaluated: vehicle, 200 pM
formalin-inactivated toxoid or 20 pM heat-inactivated BoNT/A
(Figure 5A). There were no apparent differences among the con-
trol treatments in inter-burst intervals (IBI; Figure 5B) or the
number of APs per burst over 30min (Figures 5C,D). All con-
trols exhibited a non-significant trend toward fewer APs and
more sub-threshold EPSPs over time, presumably due to intra-
cellular ionic changes caused by dialysis. Perfusion with BoNT/A
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FIGURE 5 | Acute disinhibition of network activity following
superfusion of BoNT/A. (A) Representative current-clamp recordings
demonstrating the acute effects of superfusion with vehicle (ERB; top) or
BoNT/A (ERB with BoNT/A; bottom) on AP bursting behavior (n = 7 each).
(B) Comparisons of mean inter-burst intervals in vehicle-treated (black) and
BoNT/A-treated (red) networks from −5 to 30min after superfusion (n = 7
each). (C) Expanded time-scale illustrating representative bursting patterns
before and after superfusion. (D) Comparisons of mean APs per burst in
vehicle-treated (black) and BoNT/A-treated (red) networks from −5 to
30min after superfusion (n = 7 each). In (A,B,D), the bar signifies
superfusion. All data are normalized to baseline values calculated over the
5min window immediately prior to superfusion (−5 to 0min) and compared
between equivalent time windows between treatment groups. * indicates a
P < 0.05; ** indicates a P < 0.01; *** indicates a P < 0.001.
significantly increased IBI and APs per burst within 10min, con-
firming network disinhibition (Figures 5A–D). By 30min after
toxin addition, baseline firing patterns had changed from fre-
quent, short bursts with average durations of 0.7 ± 0.2 s to
epileptiform-like bursts lasting 3.6 ± 0.3 s (p < 0.01). Collec-
tively, these studies confirm that BoNT/A addition selectively
impairs GABAergic signaling withinminutes, leading to the rapid
disinhibition of network activity.
Discussion
Using detailed electrophysiological and molecular studies, we
demonstrate that networked neuron cultures derived from
embryonic stem cells undergo impaired synaptic transmission in
response to BoNT/A intoxication. Near-total silencing of synap-
tic activity was observed within 3 h of toxin addition and was
not attributable to cytotoxicity or disrupted intrinsic electri-
cal properties. Measurements of synaptic activity revealed that
GABAergic synapses are intoxicated at least 7-fold more rapidly
than glutamatergic synapses. These findings were corroborated
by ICC studies indicating that SNAP-25 initially accumulates in
GABAergic terminals, as well as in network-level assays showing
acute disinhibition of spontaneous firing following toxin addi-
tion. Not only are ESNs the first cell-based model to replicate
the in vivo pathophysiologies responsible for clinical botulism,
but the presence of synaptically driven network responses also
allowed elucidation of synapse- and network-level responses to
intoxication with multiple levels of resolution.
An intriguing finding of this study was the identification of
synapse-specific latencies of intoxication. In networks contain-
ing excitatory and inhibitory inputs, subtle changes in the E/I
ratio can have large effects on network behavior (McCormick
and Contreras, 2001). In ESNs, the accelerated intoxication of
GABAergic synapses acutely disinhibits network behavior, driv-
ing a transition from stochastic firing to prolonged bursts, fol-
lowed ultimately by network silencing as glutamatergic synapses
are intoxicated. Observations of synapse subtype-specific laten-
cies are consistent with in vitro observations of disinhibited net-
work responses following addition of BoNT/A to primary cor-
tical or spinal cord neurons on planar microelectrode arrays
(Scarlatos et al., 2008; Pancrazio et al., 2014) as well as in vivo
reports of seizures following the intrahippocampal administra-
tion of BoNT/B (Broer et al., 2013). The rapid elimination
of GABAergic signaling by BoNT/A treatment also suggests
that functional assays directly (MIST) or indirectly (network
responses) measuring the integrity of inhibitory neurotransmis-
sion could be leveraged as highly sensitive, specific and rapid
methods to detect the presence of active BoNT.
While previous studies have attempted to elucidate the rates
of various steps associated with BoNT/A uptake and activation in
vitro, none have exploited the critical balance of spontaneous net-
work behavior to provide a sensitive metric of toxin activity. The
short latency of GABAergic intoxication suggested that BoNT/A
is rapidly internalized and activated in GABAergic synapses
in spontaneously active neuron cultures. Previous studies have
shown that binding of BoNT/A to cognate pre-synaptic receptors
can occur in solution within 1min (Vazquez-Cintron et al., 2014),
while inhibitory neurotransmission was reported to be decreased
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in spinal cord synaptic bouton preparations within 15min of
BoNT/A addition (Akaike et al., 2010). Internalization of small
quantities of BoNT/A are sufficient to paralyze whole nerve ter-
minals (Sudhof and Scheller, 2003), in part attributable to the
pre-synaptic accumulation of LC/A and the LC/A kcat = 60 s
−1
(Chen and Barbieri, 2006). Thus, while the rates of GABAergic
intoxication were unexpectedly fast, these findings are not incon-
sistent with published studies exploring kinetic and mechanistic
aspects of BoNT intoxication.
Based on these and other studies, we can postulate several
potential mechanisms to explain neuron subtype-specific laten-
cies of intoxication. First, rates of synaptic vesicle endocyto-
sis are activity-dependent, such that exposure of neurons to
BoNT/A under depolarizing conditions accelerates toxin uptake
and SNAP-25 cleavage (Simpson, 2004; Vazquez-Cintron et al.,
2014). Inhibitory neurons have been reported to have increased
firing rates compared to excitatory neurons (Wu et al., 2005;
Clayton and Cousin, 2009; Roxin et al., 2011; Becchetti et al.,
2012), and therefore may take up toxin more rapidly. Second,
differential expression of BoNT/A co-receptors could increase
selectivity for GABAergic synapses. In cortical neurons SV2A
expression is predominantly associated with GABAergic synapses
while SV2B is predominantly associated with glutamatergic
synapses (Yeh et al., 2010). While both isoforms can act as BoNT
receptors, SV2A has a higher affinity for BoNT/A and there-
foremay increase toxin internalization into GABAergic terminals
(Dong et al., 2006; Blum et al., 2012). Third, structural differences
between GABAergic and glutamatergic neurons, such as mor-
phology (Benson et al., 1994) or pre-synaptic structure (Kuzirian
and Paradis, 2011), may also contribute to differential rates of
intoxication.
Though cleavage of SNAP-25 is the molecular mechanism
underlying BoNT/A-mediated paralysis, the relationship between
the spatiotemporal production of cleaved SNAP-25 (cSNAP-25)
and decremented synaptic function has been difficult to estab-
lish. In vivo studies conducted in mice and frogs suggest that
cleavage of less than 12% of total cellular SNAP-25 is sufficient to
reduce acetylcholine release to below threshold in neuromuscular
junctions (NMJs) (Raciborska et al., 1998; Meunier et al., 2003),
whereas in vitro studies conducted in immature primary neu-
ron cultures have suggested a linear inverse correlation between
K+-induced bulk release of glutamate and SNAP-25 cleavage
(Foran et al., 2003). In ESNs, cSNAP-25 was found to accumu-
late specifically in the pre-synaptic compartment at early time-
points, ostensibly as a result of the pre-synaptic entry of LC/A.
Furthermore, cleavage of less than 3% of total cellular SNAP-25
was found to be sufficient to silence over 70% of synaptic activ-
ity. Since SNAP-25 is axolemmally distributed, a large fraction
of SNAP-25 is not directly associated with pre-synaptic compart-
ments (Tao-Cheng et al., 2000). The disproportionate sensitivity
of synaptic activity to cSNAP-25 production therefore leads us
to propose that the specific cleavage of the small subpopulation
of SNAP-25 that is involved in neurotransmitter release is suffi-
cient to block synaptic transmission. This hypothesis is consistent
with accumulation of cSNAP-25 at SYN1+ puncta after BoNT/A
addition. It would furthermore explain the increased sensitivity
of MIST compared to immunoblots, in which cleavage of the
small fraction of total SNAP-25 that is accessible to LC in the
pre-synaptic compartment may be undetectable by immunoblot.
At later time points, diffusion of intact SNAP-25 into the nerve
terminal would result in the increased production of cSNAP-25,
ultimately reaching quantities detectable by immunoblot.
Although the increased sensitivity ofMIST assays (10–30min)
vs. molecular readouts (1 h by ICC or 2 h by immunoblot) may be
attributable to the comparatively poor sensitivity of immunoblot-
based assays, we cannot exclude the possibility that BoNT/A
also impairs synaptic release via mechanisms independent of
SNAP-25 cleavage. For example, the interaction between LC/A
and SNAP-25 may sterically interfere with the formation of the
ternary complex, thereby preventing synaptic vesicle fusion and
neurotransmitter release independent of SNAP-25 cleavage. We
anticipate that recently developed catalytically defective BoNT/A
variants will offer improved tools to more directly address this
possibility (Vazquez-Cintron et al., 2014).
It has been argued that SNAP-25 is not required for GABAer-
gic neurotransmission, based on bulk release studies from synap-
tosomal preparations in the presence of BoNT/A (Frassoni et al.,
2005). While this may be true for certain GABAergic neurons,
neurotransmission has been found to be SNAP-25-dependent in
multiple primary GABAergic populations. For example, trans-
fection of intact SNAP-25 into hippocampal neurons harvested
from homozygous SNAP-25 knockouts has been shown to res-
cue GABAergic neurotransmission (Tafoya et al., 2006, 2008;
Delgado-Martinez et al., 2007). Furthermore, intoxication with
BoNT/A2, which targets SNAP-25, silences GABAergic and
glycinergic neurotransmission in rat spinal cord synaptic bouton
preparations (Akaike et al., 2010). Consistent with these studies,
we found that intoxication with BoNT/A and cleavage of SNAP-
25 in GAD1+ pre-synaptic terminals is correlated with the loss
of post-synaptic detection of monosynaptic inhibitory events,
confirming that intact SNAP-25 is necessary for GABAergic
neurotransmission in ESNs.
GABAergic signaling involves inhibition of both pre-synaptic
release probabilities via metabotropic GABARB and post-
synaptic detection via ionotropic GABARA (Wang et al., 2003;
Chalifoux and Carter, 2011). Although we did not directly iso-
late and quantify GABARB function in intoxicated neurons, the
reduction in mIPSCs following BoNT/A addition suggests that
GABARB-mediated effects on neurotransmission may also be
reduced. Since GABARB has a long-lasting, depressive effect on
pre-synaptic release, impairment of GABARB signaling is likely
to have contributed to the observed increase in mPSC detection
at 30–49min.
The NMJ, ganglia, and autonomic synapses of the PNS are
considered the clinically relevant targets of BoNT intoxication.
However, the possibility that peripherally administered BoNT
can lead to central nervous system intoxication is currently being
debated. Recent findings in vitro and in vivo suggest that BoNT/A
may undergo retrograde transport and be released from motor
neurons to intoxicate central synapses (Restani et al., 2012a,b;
Marchand-Pauvert et al., 2013). Furthermore, the direct admin-
istration of BoNT has been proposed as a potential therapeu-
tic for several indications, including epilepsy-induced seizures
(Kato et al., 2013). The observation of subtype-specific latencies
of intoxication in this study raises the possibility that intoxi-
cation of central neuronal networks containing excitatory and
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inhibitory synapses will result in complex, multiphasic behaviors
in a dose- and time-specific fashion. The effects of CNS exposure
to BoNT are likely to be dynamic and difficult to predict, influ-
enced by factors such as spatial and temporal differences in toxin
concentration, the functions of exposed neurons and local circuit
topology. These findings also raise the possibility that altering
dosing levels in a controlled fashion in specific brain regions may
allow the purposeful modulation of particular neuronal circuits.
In conclusion, we have found that synaptically coupled, net-
worked populations of ESNs undergo blockade of synaptic neu-
rotransmission following exposure to BoNT/A, confirming that
ESNs replicate the pathophysiologies that are responsible for the
clinical manifestations of botulism. These studies validate the
use of synaptically active and networked ESNs as a replacement
for primary neurons in BoNT studies, offering a novel, biologi-
cally relevant, cost-effective, and scalable platform for the specific
and sensitive study of toxin that does not require animal use or
rely on non-neuronal models with dubious relevance. They fur-
thermore indicate that synaptically coupled populations of stem
cell-derived neurons offer a relevant model for therapeutic dis-
covery, in which the functional effects of toxin:host interactions
are highly conserved and thus likely to be translatable to the PNS.
The application of synaptic function-based assays to function-
ally detect the presence of BoNT/A within minutes or hours of
exposure is a significant improvement over existing techniques
to measure active toxin in situ, which are slower and either less
specific (e.g., the mouse lethality assay) or less sensitive (e.g.,
immunoblots). Finally, the specificity rendered by electrophysio-
logical measurements of synaptic activity indicates that ESNsmay
be suitable for the study of other pre-synaptically targeted tox-
ins, such as tetanus or the remaining BoNT serotypes. Exploita-
tion of this scalable model for BoNT research will lead to better
understanding of synaptic and network responses to intoxica-
tion and provide a relevant platform for rapid toxin detection,
improved potency determination and development of medical
countermeasures.
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